19 November 2018
Commentary by Dr Dan Grant, originally published in The Mandarin on November 16, 2018.
16 November 2018
The MTPConnect team continue to work hard to grow the medtech and pharma sector. Here are some of the key activities from the last week.
14 November 2018
MTPConnect, the national Growth Centre for the Medical Technologies and Pharmaceuticals Sector, has extended its alliance with the Medical Technology Association of Australia.
09 November 2018
The BridgeTech Program will be holding its main event of the year, the BridgeTech Symposium, for its inaugural cohort at the stellar location of Luna Park, Sydney.
08 November 2018
Australia is considered one of the first movers in the regenerative medicine (RM) space, with more than 70 institutes and companies working in the sector across the country.
07 November 2018
Industry 4.0 is not just a fad—it is a real event, said an expert at The Medtech Conference.
05 November 2018
eMotionGait, wearable tech for the informed support of lower limb amputees, wins Perth Biodesign pitch night
Medical device start-up JR-TeCH, creators of eMotionGait, a wearable technology for prostheses, has taken first prize at the 2018 Perth Biodesign Pitch Night, presented by Accelerating Australia.
01 November 2018
MTPConnect has expanded its alliance with national life sciences organisation AusBiotech.
31 October 2018
A new report on opportunities for Australia’s burgeoning regenerative medicine sector reveals it has all the elements needed to be a global leader and drive the creation of thousands of new, high paying jobs.
26 October 2018
MTPConnect, the national growth centre for the medical technology, biotechnology and pharmaceutical sector, and Queensland peak industry group Life Sciences Queensland have expanded their alliance to help grow Australian life sciences.
25 October 2018
The CSIRO protein production platform in Melbourne and the Medical Device Partnering Program (MDPP) based at Flinders University in Adelaide are the latest MTPConnect projects to attract additional investment from Australian State governments.
24 October 2018
Melbourne-headquartered Cancer Therapeutics CRC (CTx) announced a two-year research collaboration and a license agreement with Pfizer Inc. (NYSE: PFE).
10 October 2018
Three key life sciences projects have been awarded a total of $690,000 in new funding to support researchers, improve collaboration with industry and open-up international market opportunities.
09 October 2018
From virtual reality for kids to novel surgical equipment Australia’s health innovations under development will be on display to the world at the World Hospital Congress in Brisbane.